Simon D. Baines

University of Hertfordshire — United Kingdom

Medicine · Health Sciences

26h-index3.0kcitations50works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Clostridium difficile and Clostridium perfringens research(45), Microscopic Colitis(25), Viral gastroenteritis research and epidemiology(20), Antimicrobial Resistance in Staphylococcus(9), Nosocomial Infections in ICU(9)

Publications50 total

Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model
Antibiotics·2023· 7 citedOpen Access
Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico
Enfermedades infecciosas y microbiologia clinica (English ed )·2022· 1 cited
Diversity of Circulating <i>Clostridioides difficile</i> Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Microbial Drug Resistance·2021· 2 cited
Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico
Enfermedades Infecciosas y Microbiología Clínica·2021· 6 cited
Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes
Journal of Microbiological Methods·2020· 30 cited
#HowToPPA: An Examination of the Regulatory and Commercial Challenges and Opportunities Arising in the Context of Private Power Purchase Agreements for Renewable Energy
Alberta Law Review·2019· 5 citedOpen Access
2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
Open Forum Infectious Diseases·2019Open Access
High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates
PLoS ONE·2019· 23 citedOpen Access
502. Enhanced Sporulation and Vancomycin Resistance Associated With <i>Clostridium difficile</i> From Recurrent Infections
Open Forum Infectious Diseases·2018Open Access
Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria
PLoS Pathogens·2018· 127 citedOpen Access
Circulation of Highly Drug-Resistant <i>Clostridium difficile</i> Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico
Microbial Drug Resistance·2018· 15 cited
Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome
PLoS ONE·2017· 54 citedOpen Access
Design, Synthesis and Antimicrobial Evaluation of the in vitro Efficacy of Novel Diketones
University of Hertfordshire Research Archive (University of Hertfordshire)·2015
In vitro assessment of Clostridium difficile PCR ribotype 002: the most prevalent C. difficile ribotype in the United Kingdom.
University of Hertfordshire Research Archive (University of Hertfordshire)·2015
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection
Antibiotics·2015· 69 citedOpen Access
<i>In vitro</i> susceptibility of <i>Clostridium difficile</i> to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against <i>C. difficile</i>
Journal of Antimicrobial Chemotherapy·2015· 40 citedOpen Access
SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model
Journal of Antimicrobial Chemotherapy·2014· 42 citedOpen Access
Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model
Journal of Antimicrobial Chemotherapy·2014· 46 citedOpen Access
Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota
PLoS ONE·2014· 47 citedOpen Access
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection
Journal of Antimicrobial Chemotherapy·2013· 63 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jane Freeman(33), Mark H. Wilcox(25), Warren N. Fawley(10), S. L. Todhunter(10), M. H. Wilcox(9), G. S. Crowther(9), C. H. Chilton(9), Adrián Camacho-Ortíz(9), Elvira Garza‐González(9), Rayo Morfín‐Otero(8), Licet Villarreal-Treviño(8), Adrián Martínez-Meléndez(7), Katie Saxton(4), Rory J O’Connor(4), Katherine Saxton(4), Richard Vickers(4), G. S. Huscroft(4), Laura Tijerina-Rodríguez(4), Eduardo Rodríguez-Noriega(4), Sarah Underwood(3)